ArticleAlcohol, clinical & experimental research2025
Rat models of fetal alcohol spectrum disorders for studying the critical role of cerebellar damage: A scoping review.
Article in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hesperidin mitigates cognitive and anxiety-like deficits by enhancing hippocampal antioxidant defenses, reducing neuroinflammation, and preventing neuronal apoptosis in a third-trimester-equivalent rat model of developmental ethanol neurotoxicity.IBRO neuroscience reports · 2026Article
- Subtle Cognitive Variability in Foetal Alcohol Syndrome Spectrum: Intelligence Profiles and Verbal Fluency Performance Across Diagnostic Categories in Polish Population.Journal of clinical medicine · 2026Article
- Rat models of fetal alcohol spectrum disorders for studying the critical role of cerebellar damage: A scoping review.Alcohol, clinical & experimental research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundFetal alcohol spectrum disorder (FASD) refers to the neurodevelopmental condition of lifelong cognitive, emotional, and behavioral challenges that can occur in individuals exposed to alcohol before birth. FASD is a preventable, chronic condition with no direct diagnosis and no treatment, and is considered the leading cause of developmental cognitive impairment in Western countries. The best-known effects of prenatal alcohol exposure (PAE) are those that affect the brain. Among these structures, the cerebellum, a key coordinative tissue, is particularly sensitive to PAE, leading to motor and cognitive disorders. Since 1994, the use of different rat models of FASD has greatly influenced the understanding of the effects of perinatal alcohol exposure on cerebellum development.
methodsWe conducted a scoping review of research from the past 30 years to answer an important question for the scientific community: "Which rat model of Fetal Alcohol Spectrum Disorders (FASD) offers the most relevant insights for selecting an appropriate experimental design, specifically for investigating alcohol-induced effects on the cerebellum?"
resultsConsidering the unique developmental characteristics of the cerebellum, five developmental time windows have been identified in rats for studying its state after ethanol exposure. In each window, the route and dose of ethanol administration result in different blood alcohol concentration (BAC) levels, each with distinct advantages and disadvantages. This information is presented in three tables, which also indicate the type of study conducted: morphological, biochemical, electrophysiological, or behavioral.
conclusionsThe third-trimester equivalent period is the most susceptible to alcohol-induced cerebellar damage and is thus the most widely studied by researchers. More research is needed on the effects of alcohol during lactation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.